BGI NGS Solution

Introduction

BGI is changing diagnostics by providing fast, affordable and comprehensive genetic knowledge. Genetic disease raises many questions. We’re empowering healthcare providers with the information they need to answer these questions, in order to both prevent disease and better guide patient treatment decisions. With more than 5 years’ experience in diagnostic testing and screening, and a worldwide network of offices and laboratories, BGI acts as one of the world’s most tried and trusted clinical genomics partners.

Our Technology

BGISEQ-500 is an industry leading high-throughput sequencing solution, powered by combinatorial Probe-Anchor Synthesis (cPAS) and improved DNA Nanoballs (DNB) technology. The cPAS chemistry works by incorporating a fluorescent probe to a DNA anchor on the DNB, followed by high-resolution digital imaging. This combination of linear amplification and DNB technology reduces the error rate while enhancing the signal. In addition, the size of the DNB is controlled in such a way that only one DNB is bound per active site. This patterned array technology not only provides sequencing accuracy, but it also increases the chip utilization and sample density.

Our Workflow

1. Preparation

2. On-site Training

3. Technical Support

*Add-on services for purchase

Join Our Network

London, UK

Copenhagen,Denmark
Cambrige, MA, USA
BGISEQ-500 is an industry leading high-throughput sequencing solution, powered by combinatorial Probe-Anchor Synthesis (cPAS) and improved DNA Nanoballs (DNB) technology. The cPAS chemistry works by incorporating a fluorescent probe to a DNA anchor on the DNB, followed by high-resolution digital imaging. This combination of linear amplification and DNB technology reduces the error rate while enhancing the signal. In addition, the size of the DNB is controlled in such a way that only one DNB is bound per active site. This patterned array technology not only provides sequencing accuracy, but it also increases the chip utilization and sample density.